>
The genu recurvatum market has seen noticeable shifts over time. This is evident in the fact that, there has been a change from ordinary to advanced treatments for this condition. Genu recurvatum has become an important subject of investigation by orthopedic experts and scientists due to technological advancements being made in the healthcare industry with a view to finding new effective solutions.
An increase in the prevalence of minimally invasive procedures is one outstanding trend associated with genu recurvatum. It is all about the desire for faster recovery and lesser post-surgical complications which are forcing both physicians and patients to develop preference for less invasive treatment alternatives. In addition to providing a better patient experience, such methods contribute to shorter hospital stays making them more economical. Therefore, manufacturers and doctors are investing into research and development in order to improve as well as expand minimally invasive fixes of genu recurvatum.
Furthermore, the adoption of patient-specific implants and personalized treatment plans has risen highly within the genu recurvatum market. With newer imaging technologies such as 3D imaging and computer-aided design (CAD), orthopedic surgeons can now create custom-made implants that fit exactly along an individual’s anatomical structure. Tailoring a plan helps achieve better therapeutic outcomes among other things. As medicine becomes more personalized, it recognizes each person as unique entity in terms of care provision through precision medicine
Regenerative medical practices have become another area of immense interest within genu recurvatum marketspace . These approaches aim at addressing the root causes of genu recurvatum by using stem cell therapy as well as tissue engineering. They concentrate on promoting tissue regeneration and repair which may be useful over longer durations in overcoming this problem faced by individuals suffering from this disease process. As research on regenerative medicine continues different stakeholders like biotech companies, universities among others will come together thus making strides towards advancement.
Genu recurvatum market also experiences considerable growth prospects in the field of regenerative medicine. Stem cell therapy and tissue engineering are emerging as promising avenues for addressing the underlying causes of genu recurvatum. These innovative approaches focus on promoting tissue regeneration and repair, offering a potential long-term solution for patients suffering from this condition. As research in regenerative medicine continues to progress, collaborations between academic institutions, biotechnology companies, and healthcare providers are likely to increase, driving further advancements in treatment modalities.
There is also an upswing in awareness campaigns and educational efforts within the genu recurvatum market. Acquisition of knowledge about the illness occurrence, prevention measures or even possible treatments is becoming more widespread among sufferers themselves. An increased number of information sources has resulted from medical service providers’ involvement, patient support groups assisting them at various stages till recovery.
However, there still exist some barriers like affordability issues and reimbursement policies that continue to affect the genu recurvatum market significantly even today. Although these advanced technologies come with numerous benefits to their users such as personalized treatments options; they only remain accessible to a limited population due to high cost implications associated with them. Striking a balance between innovation and affordability will be crucial for ensuring widespread adoption of these advancements.”
Genu Recurvatum Market Size was valued at USD 0.32 Billion in 2023. The Global Genu Recurvatum industry is projected to grow from USD 0.53 Billion in 2024 to USD 1.48 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.98% during the forecast period (2024 - 2032).
Genu Recurvatum is a rare orthopedic complication in which the hyperextension of the knee is greater than five degrees. It is also known as back knee or knee hyperextension. It occurs more frequently in females than it does in males, and is commonly, identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA). This condition causes stress in the posterior knee structures which cause permanent damage of the joint. Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial ostotomies.
Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is an extremely rare condition, and found to be associated with other malformations such as talipes equinovarus, hip dysplasia, and absent patella. Signs and symptoms of this medical condition includes pain in the inner-leg portion of knee also known as medial tibiofemoral joint, pain in the outer back portion of knee also known as posterolateral ligamentous structures, extension of gait pattern, and difficulty in performing endurance activities.
Genu recurvatum can be of three types, i.e. external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD). Out of three, ERD, and NRD are more severe, as ERD leads to soft tissue damage in which lower legs angle outward. Whereas, NRD, produces stress to the posterior soft tissue structures of knee. In some developing, and under developed regions, burden of orthopedics condition is rising due to lack of awareness.
According to a study published in Indian Journal of Orthopaedics (IJO) in 2016, deficient orthopedic services and education such as, poor surgeon–patient ratio, poorly trained physicians to deal with musculoskeletal emergencies, and absence of minimum standard of orthopedic care, have been observed in some part of India. However, the Indian Orthopaedic Association (IOA) along with government health planners, individual medical practitioners, and medical educationists are working to find remedial solutions to these problems.
Notably, the market is expected to expand in the near future due to rise in geriatric population, high unmet needs of current treatment, and increase in research and development expenditure. Increase in aging population is the major market driver because the risk of orthopedic disorders increases exponentially with age. According to the data suggested by WHO in 2015, it is found that, worldwide, one in eight people was aged 60 years or over and by 2030, older people are projected to account for one in six people globally.
Despite these drivers, there are some issues associated with genu recurvatum market. High cost of treatment & management of genu recurvatum and related disorders, and lack of infrastructure in middle and low income countries may hamper the growth of the Genu Recurvatum Market.
Intended Audience
The Genu recurvatum market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, market is segmented into external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD).
On the basis of diagnosis, market is segmented into magnetic resonance imaging (MRI), X-rays, and others.
On the basis of treatment, market is classified into physical therapy, orthoses, bracing, and surgery.
On the basis of end-user, market is segmented into hospital, clinics, and others.
The Americas dominate the Genu recurvatum market owing to the rising awareness among people, and increasing healthcare expenditure. The Centers for Disease Control and Prevention (CDC) has stated that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States. Furthermore, increasing participation of bigger players and new marketers towards advancement in treatment approaches have also attracted a great deal of attention.
Europe holds the second position in the Genu recurvatum market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.
Asia Pacific is the fastest growing Genu recurvatum market owing to the huge patient pool and developing healthcare technology.
The Middle East & Africa has the lowest market for rabies treatment market due to lack of technical knowledge and poor medical facilities.
Some of key the players in the Genu Recurvatum Market are:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)